Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;37(1):57-64.
doi: 10.2337/cd18-0006.

A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 Diabetes

Kurt Midyett  1 , Jeffrey R Unger  2 , Eugene E Wright  3 , Timothy D Daniel  4 , Davida F Kruger  5 , Robert R Henry  6 , Refaat A Hegazi  7
Affiliations

A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 Diabetes

Kurt Midyett et al. Clin Diabetes. 2019 Jan.

Abstract

IN BRIEF Glucose variability is a potential independent risk factor of poor clinical outcome among people with diabetes, with adequate measurement technically difficult and cumbersome. For this study, a novel 14-day continuous sensor was used to assess glucose variability among people with type 2 diabetes (T2D). The aim was to characterize glucose profiles for up to 2 weeks in T2D and to survey device utilization in a standard clinical setting and its potential to collect clinically meaningful data.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Comparison of AGP at the same laboratory A1C (A1–A4 = 6.0%, B1–B4 = 10.0%). Met, metformin.
See this image and copyright information in PMC

References

    1. Kovatchev B, Cobell C. Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care 2016;39:502–510 - PMC - PubMed
    1. Monnier L, Wojtusciszyn A, Colette C, Owens D. The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol Ther 2011;13:813–818 - PubMed
    1. Lipska KJ, Warton EM, Huang ES, et al. . HbA1c and risk of severe hypoglycemia in type 2 diabetes. Diabetes Care 2013;36:3535–3542 - PMC - PubMed
    1. Murata GH, Hoffman RM, Shah JH, Wendel CS, Duckworth WC. A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: the Diabetes Outcomes in Veterans Study (DOVES). Arch Intern Med 2004;164:1445–1450 - PubMed
    1. Mazze RS, Lucido D, Langer O, Hartmann K, Rodbard D. Ambulatory glucose profile: representation of verified self-monitored blood glucose data. Diabetes Care 1987;10:111–117 - PubMed